via Harbin Institute of Technology
The research team of Professor He Qiang and Professor Wu Zhiguang from the Micro-Nano Technology Research Center of our school realized the active targeted treatment of glioma by swimming micro-nano robots for the first time, The research results were published online in the journal Science Robotics with the title “Dual-responsive biohybrid neutrobots for active target delivery”. Professor He Qiang and Professor Wu Zhiguang are the co-corresponding authors of the paper, and 2016 doctoral student Zhang Hongyue is the first author of the paper.
Glioblastoma (GBM) is one of the most difficult cancers to treat effectively. In the world, the number of cases and deaths in China is the highest. The important reason is the lack of precise therapy, and due to the existence of blood-brain barrier and blood-tumor barrier, the treatment approaches to intracranial tumor sites are limited. How to make drugs break through the blood-brain barrier, realize the active targeted delivery of drugs, and improve the curative effect of drugs on glioma has become a bottleneck problem in glioma medical field for a long time.
To solve this problem, the research team developed a swimming micro-nano robot based on immune cells in vivo, which was prepared by neutrophils phagocytosis of magnetic drug-loaded hydrogel wrapped in Escherichia coli membrane. The swimming micro-nano robot can effectively and stably carry anticancer drugs?such as paclitaxel. Relying on the self-developed control system, the swimming micro-nano robot is guided to the brain region, and the robot reaching the glioma region can autonomously sense the pathogen signal and swim to the patient site after crossing the blood-brain barrier, thus accurately releasing the drug to the patient, which is significantly improving the targeting efficiency of the drug. These research results establish that the swimming micro-nano robot based on immune cells is a potential precise therapy for glioma and can be used for systematic treatment of glioma.
Original Article: The micro-nano center has made important progress in the research of swimming micro-nano robot in the treatment of glioma
More from: Harbin Institute of Technology
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Swimming micro-nano robot
- Carbon-Based Tiny Robots Could Revolutionize Various Industries
In explaining his research, the professor in the Department of Mechanical Engineering alludes to the 1966 science-fiction film Fantastic Voyage, about a submarine vessel and its crew shrunk to microsc ...
Go deeper with Google Headlines on:
Swimming micro-nano robot
[google_news title=”” keyword=”swimming micro-nano robot” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Glioblastoma
- Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances in Treatment Protocols and Drug Developments
The "Glioblastoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest report on the Glioblastoma pipeline insights covers extensive research into the ...
- New Therapy Destroys Deadly Brain Tumor in Days
A groundbreaking new therapy destroys deadly brain tumors within days. The new treatment, CAR T-cell therapy, helps treat glioblastoma.
- Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion ...
- ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Investigator-Initiated Glioblastoma Trial
ITM-31 is a carbonic anhydrase (CA) XII-specific antibody Fab fragment developed by Helmholtz Munich and coupled with ITM's medical radioisotope, non-carrier-added Lutetium-177 (n.c.a. 177 Lu, ...
- Genetically engineering a treatment for incurable brain tumors
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 ...
Go deeper with Google Headlines on:
Glioblastoma
[google_news title=”” keyword=”glioblastoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
